Immunotherapy, namely anti-PD-1/PD-L1 antibodies, has extensively demonstrated efficacy in many solid tumors, but proved of limited success in colorectal cancer with both low vitamin D and high NLR being associated with inferior drug efficacy [51,52,53,54]. Here, CD274 is linked to colorectal cancer.